The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 05, 2010
Filed:
Oct. 31, 2007
Douglas Charles Hanson, Niantic, CT (US);
Mark Joseph Neveu, Hartford, CT (US);
Eileen Elliott Mueller, Old Lyme, CT (US);
Jeffrey Herbert Hanke, Reading, MA (US);
Steven Christopher Gilman, Cambridge, MA (US);
C. Geoffrey Davis, Burlingame, CA (US);
Jose Ramon Corvalan, Foster City, CA (US);
Douglas Charles Hanson, Niantic, CT (US);
Mark Joseph Neveu, Hartford, CT (US);
Eileen Elliott Mueller, Old Lyme, CT (US);
Jeffrey Herbert Hanke, Reading, MA (US);
Steven Christopher Gilman, Cambridge, MA (US);
C. Geoffrey Davis, Burlingame, CA (US);
Jose Ramon Corvalan, Foster City, CA (US);
Amgen Fremont Inc., Fremont, CA (US);
Pfizer Inc., New York, NY (US);
Abstract
In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.